Clinical Trial Update: Safety, Tolerability and Pharmacokinetics Study of EGT0001474 in Subjects With Type 2 Diabetes [Phase 1]

View source ↗

Summary

Phase 1 safety, tolerability, and pharmacokinetics study of EGT0001474 in subjects with type 2 diabetes has been completed with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• EGT0001474

Snippet

Sponsor: Theracos | Conditions: Diabetes Mellitus Type 2 | Phase 1 | Status: COMPLETED | Results posted: 2011-08-17